TNF Pharmaceuticals Inc (TNFA) concluded trading on Wednesday at a closing price of $0.25, with 3.36 million shares of worth about $0.84 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -84.74% during that period and on April 16, 2025 the price saw a loss of about -9.00%. Currently the company’s common shares owned by public are about 3.36M shares.
Stock saw a price change of -2.31% in past 5 days and over the past one month there was a price change of -36.84%. Year-to-date (YTD), TNFA shares are showing a performance of -78.63% which decreased to -89.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.21 but also hit the highest price of $3.37 during that period. The average intraday trading volume for TNF Pharmaceuticals Inc shares is 957.71K. The stock is currently trading -26.65% below its 20-day simple moving average (SMA20), while that difference is down -39.54% for SMA50 and it goes to -79.96% lower than SMA200.
TNF Pharmaceuticals Inc (NASDAQ: TNFA) currently have 3.36M outstanding shares and institutions hold larger chunk of about 5.54% of that.
The stock has a current market capitalization of $2.49M and its 3Y-monthly beta is at 2.12. It has posted earnings per share of -$11.73 in the same period. It has Quick Ratio of 1.40 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TNFA, volatility over the week remained 15.55% while standing at 14.22% over the month.
